ARVC diagnostic criteria | Criteria fulfilled | Subject | |||||
---|---|---|---|---|---|---|---|
 |  | Family I.1 | Family II.1 | Family II.2 | Family III.1 | Family III.2 | Family IV.1 |
Sex | Â | M | M | M | F | M | M |
Age at diagnosis (years) | Â | 41 | 20 | 17 | 35 | 18 | 16 |
Global and regional dysfunction and structural alterations | Major | 1 | 1 | 1 | Â | 1 | 1 |
 | Minor |  |  |  | 1 |  |  |
Tissue characterization | Major | Â | Â | 1 | Â | NA | Â |
 | Minor |  |  |  |  |  |  |
Repolarization abnormalities | Major | Â | Â | Â | Â | NA | Â |
 | Minor |  |  |  |  |  |  |
Depolarization/conduction abnormalities | Major | Â | Â | Â | Â | NA | Â |
 | Minor |  |  |  |  |  |  |
Arrhythmias | Major | 1 | 1 | 1 | Â | NA | 1 |
 | Minor |  |  |  |  |  |  |
Family history | Major | Â | 1 | 1 | NA | NA | Â |
 | Minor |  |  |  |  |  |  |
Mutation |  | DSG2, c. 208A > G†(Ile70Val), PKP2a, c.397 C > T (Gln133*) | DSC2, C.1234-35insA†,(p.Thr412Asnfs*2) | DSC2, C.1234-35insA†, (p.Thr412Asnfs*2) | PKP2, c.2540 delT†, (p.Leu847Argfs*83) | PKP2, c.2540 delT†, (p.Leu847Argfs*83) | PKP2, C.2197-2202delinsG, (p.His733Alafs*8) |
Predicted functional effect | Â | DSG2, Ile70Val, Benign | Â | Â | Â | Â | Â |
Mutation screening in 150 normal healthy controls | Â | Absent | Absent | Absent | Absent | Absent | ND (reported earlier) |